View details of this raise on Seedstage

Encino, CA

Expanding development and clinical research of a patented nano-formulated supplement to support long-term brain health.

• Flagship product: Brain Protect™, a nano-formulated supplement developed through years of neuroscience research.
• Scientific validation: Pre-clinical studies demonstrated efficacy, with findings published in peer-reviewed journals.
• Innovative delivery: Patented nanotechnology enhances absorption and enables nutrients to cross the blood-brain barrier.
• Market growth: Positioned in the rapidly expanding global brain health and nootropics markets.
• Intellectual property: Patents filed in the US, EU, and India to protect formulations and delivery systems.
• Early traction: Revenue growth driven by product sales, recurring subscriptions, and organic customer engagement.
• Experienced leadership: Team of scientists, entrepreneurs, and health experts driving strategy and innovation.

Tahiro is focused on addressing the growing global brain health crisis by advancing preventative solutions for long-term cognitive support. With aging populations and increasing awareness of neurodegenerative conditions, the company is fundraising to expand development and distribution of its flagship product, Brain Protect™, a nano-powered supplement designed to support memory, brain resilience, and overall mental wellbeing. This formula is built on years of research in nutritional neuroscience and combines clinically studied compounds including Nano Omega-5, full-spectrum pomegranate extract, and hemp extract, chosen for their potential role in promoting brain health and cognitive longevity.

The funds will support Tahiro in advancing clinical research, scaling production, and extending its market reach within the fast-growing brain health and nootropics category. With early traction from product sales and subscriptions, alongside published pre-clinical studies validating efficacy, the company is positioned to grow its platform of science-backed, transparent, and patented neuroprotective solutions. Tahiro’s approach emphasizes innovative nanotechnology delivery systems to increase effectiveness, while securing intellectual property across multiple regions. The offering represents an opportunity to back a company seeking to shape the future of preventative brain care through a combination of advanced research, patented technology, and growing consumer adoption.

Company Info

Tahiro is a neuroscience-focused company developing patented nano-formulated supplements to support long-term brain health and cognitive function.

Tahiro is a cognitive health company focused on developing solutions to support long-term brain health and mental wellbeing. Its flagship product, Brain Protect™, combines neuroprotective compounds such as Nano Omega-5, pomegranate extract, and hemp extract. The formulation is designed with nanotechnology to improve bioavailability, allowing active ingredients to cross the blood-brain barrier more effectively and support neural resilience. Early studies indicate positive results, with in-vitro tests showing protection of brain cells under stress and in-vivo studies in aged mice demonstrating improved memory and problem-solving abilities.

The company positions itself at the intersection of neuroscience and wellness, aiming to address the growing challenge of cognitive decline as global populations age. With patents filed in multiple regions, Tahiro is building intellectual property around its formulas and delivery systems. Its strategy emphasizes scientifically backed, natural, and precision-engineered approaches to brain health, differentiating it from generic supplement offerings.